PARSONS CAPITAL MANAGEMENT INC/RI
Position in RLMD — Relmada Therapeutics, Inc.
CIK 1018674
PROVIDENCE, RI
Position in RLMD
as of Mar 31, 2026
· filed Apr 15, 2026
Position Value
$2,453,400
+$1,183,110 QoQ
Shares Held
352,500
+34.0% QoQ
Ownership
0.336%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PARSONS CAPITAL MANAGEMENT INC/RI holds $8,271,929 across 6 Biotechnology names. RLMD ranks #2 (29.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,641 | $4,305,092 | |
| 2 | RLMD |
Relmada Therapeutics, Inc.
This page
|
352,500 | $2,453,400 | |
| 3 | NRXS |
Neuraxis, INC
|
116,726 | $863,772 | |
| 4 | TECH |
BIO-TECHNE Corp
|
6,852 | $358,085 | |
| 5 | MDXG |
Mimedx Group, Inc.
|
72,692 | $287,133 | |
| 6 | GTBP |
GT Biopharma, Inc.
|
10,900 | $4,447 |
All Filings in RLMD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,453,400 | 352,500 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,270,290 | 263,000 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $328,305 | 163,336 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $98,001 | 163,336 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $44,100 | 163,336 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $84,934 | 163,336 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $3,248,731 | 1,002,695 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,927,835 | 975,945 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $4,526,868 | 973,520 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $3,932,341 | 949,841 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $2,922,246 | 974,082 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $2,148,347 | 873,312 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,632,095 | 722,166 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $1,731,926 | 496,254 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $18,650,713 | 503,801 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $9,566,706 | 503,776 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $13,578,021 | 503,076 | Shares | Defined | 2022-05-02 | |
| 2021-12-31 | $11,341,872 | 503,412 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $12,396,648 | 472,974 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $14,417,688 | 450,412 | Shares | Defined | 2021-08-03 | |
| 2021-03-31 | $15,894,216 | 451,412 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $14,483,196 | 451,612 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $17,122,253 | 455,137 | Shares | Defined | 2020-10-29 | |
| 2020-06-30 | $20,320,393 | 454,087 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $14,516,363 | 425,575 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||